• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tissue-type plasminogen activator in breast cancer: relationship with estradiol and progesterone receptors.

作者信息

Duffy M J, O'Grady P, Simon J, Rose M, Lijnen H R

出版信息

J Natl Cancer Inst. 1986 Sep;77(3):621-3. doi: 10.1093/jnci/77.3.621.

DOI:10.1093/jnci/77.3.621
PMID:3091895
Abstract

Plasminogen activator (PA) is an estradiol-inducible enzyme and therefore a potential marker for a functional estradiol receptor (ER) in human breast carcinomas. In this investigation tissue-type PA (t-PA) correlated significantly with both ER and progesterone receptors (PR) in human breast carcinomas. In contrast, neither total PA activity nor urokinase-like PA showed any significant correlation with either ER or PR. Other proteases such as a trypsin-like protease, a chymotrypsin-like protease, and cathepsin B also showed no correlation with ER and PR. It was concluded that the t-PA form of PA may be a marker for a functional ER in breast carcinoma and thus be of value in predicting hormone-dependent breast cancers.

摘要

相似文献

1
Tissue-type plasminogen activator in breast cancer: relationship with estradiol and progesterone receptors.
J Natl Cancer Inst. 1986 Sep;77(3):621-3. doi: 10.1093/jnci/77.3.621.
2
Tissue-type plasminogen activator as marker of functional steroid receptors in human breast cancer.组织型纤溶酶原激活剂作为人类乳腺癌中功能性类固醇受体的标志物。
Thromb Res. 1993 Jan 15;69(2):209-20. doi: 10.1016/0049-3848(93)90046-q.
3
[Study of the cytosolic concentrations of the tissue poly-peptide specific (TPS) antigen in infiltrating ductal carcinomas of the breast. Positive relationship with hormone dependency and negative with cellular proliferation].[乳腺浸润性导管癌中组织多肽特异性(TPS)抗原胞浆浓度的研究。与激素依赖性呈正相关,与细胞增殖呈负相关]
Rev Esp Med Nucl. 2001 Aug;20(5):365-8. doi: 10.1016/s0212-6982(01)71975-1.
4
Relationship of membrane-bound tissue type and urokinase type plasminogen activators in human breast cancers to estrogen and epidermal growth factor receptors.
Cancer Res. 1988 Nov 15;48(22):6603-7.
5
Tissue-type plasminogen activator, a new prognostic marker in breast cancer.组织型纤溶酶原激活剂,乳腺癌中的一种新的预后标志物。
Cancer Res. 1988 Mar 1;48(5):1348-9.
6
[The concentration of tissue--type plasminogen activator (t-PA) in extracts of breast cancer tissue].[乳腺癌组织提取物中组织型纤溶酶原激活物(t-PA)的浓度]
Pol Merkur Lekarski. 2008 Dec;25(150):489-94.
7
Hormonal modulation of plasminogen activator: an approach to prediction of human breast tumor responsiveness.纤溶酶原激活剂的激素调节:一种预测人类乳腺肿瘤反应性的方法。
Cancer Res. 1987 Jul 1;47(13):3558-64.
8
Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.人乳腺癌中雌激素、孕激素、雄激素和糖皮质激素受体的分布、频率及定量分析。
Cancer Res. 1979 May;39(5):1447-54.
9
Thrombospondin in malignant and non-malignant breast tissue.恶性及非恶性乳腺组织中的血小板反应蛋白
Eur J Cancer Clin Oncol. 1989 Feb;25(2):343-50. doi: 10.1016/0277-5379(89)90028-x.
10
Association of plasminogen activator activity and steroid receptors in human breast cancer.
Eur J Cancer Clin Oncol. 1982 Feb;18(2):129-32. doi: 10.1016/0277-5379(82)90055-4.

引用本文的文献

1
Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer.组织型纤溶酶原激活剂(tPA)及其与1型抑制剂(PAI-1)复合物在乳腺癌中的预后价值。
Br J Cancer. 1999 Apr;80(1-2):286-94. doi: 10.1038/sj.bjc.6690353.
2
Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.雌激素对稳定表达雌激素受体的MDA-MB-231人乳腺癌细胞中纤溶酶原-纤溶酶系统各成分的调节作用
Br J Cancer. 1998 Jul;78(1):88-95. doi: 10.1038/bjc.1998.447.
3
Inhibition of postconfluent focus production in cultures of MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Breast Cancer Res Treat. 1988 Oct;12(2):227-33. doi: 10.1007/BF01805943.
4
Proteinase-like peptidase activities and oestrogen receptor levels in breast cancer tissue.乳腺癌组织中的类蛋白酶样肽酶活性和雌激素受体水平。
J Cancer Res Clin Oncol. 1989;115(1):89-92. doi: 10.1007/BF00391606.
5
Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.恶性与良性乳腺肿瘤中组织蛋白酶D、尿激酶和纤溶酶原激活物抑制剂之间的关系
Br J Cancer. 1991 Nov;64(5):926-32. doi: 10.1038/bjc.1991.428.
6
The role of proteolytic enzymes in cancer invasion and metastasis.蛋白水解酶在癌症侵袭和转移中的作用。
Clin Exp Metastasis. 1992 May;10(3):145-55. doi: 10.1007/BF00132746.